In vitro antibacterial activities of a novel oxazolidinone, OCID0050
- PMID: 19689978
- DOI: 10.1093/jac/dkp300
In vitro antibacterial activities of a novel oxazolidinone, OCID0050
Abstract
Objectives: In the pursuit of developing a second-generation oxazolidinone, we have identified OCID0050 as a novel oxazolidinone with enhanced activity against bacterial strains resistant to methicillin, vancomycin and linezolid.
Methods: MIC and MBC determinations were performed according to CLSI guidelines. Linezolid-resistant bacterial strains were generated in-house; inoculum effect, pH effect and kill kinetics experiments were performed as per standard protocols.
Results and conclusions: OCID0050 demonstrated better inhibitory potency against many of the tested clinically significant strains by generally showing 2-4-fold lower MICs than linezolid. In addition, it has higher inhibitory activity against linezolid-resistant strains.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
